These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 19023091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. G-protein-coupled receptors signaling pathways in new antiplatelet drug development.
    Gurbel PA, Kuliopulos A, Tantry US.
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):500-12. PubMed ID: 25633316
    [Abstract] [Full Text] [Related]

  • 6. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD, Lee IK, Lee WM, Cho JY, Park HJ, Oh JW, Park SC, Kim SK, Kwak YS, Yun BS, Rhee MH.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):361-7. PubMed ID: 18313047
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovery of an orally available PAR-1 antagonist as a novel antiplatelet agent.
    Lee S.
    Arch Pharm Res; 2011 Apr 28; 34(4):515-7. PubMed ID: 21544715
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New antithrombotic drugs.
    Gross PL, Weitz JI.
    Clin Pharmacol Ther; 2009 Aug 28; 86(2):139-46. PubMed ID: 19553932
    [Abstract] [Full Text] [Related]

  • 13. Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo.
    Perez M, Lamothe M, Maraval C, Mirabel E, Loubat C, Planty B, Horn C, Michaux J, Marrot S, Letienne R, Pignier C, Bocquet A, Nadal-Wollbold F, Cussac D, de Vries L, Le Grand B.
    J Med Chem; 2009 Oct 08; 52(19):5826-36. PubMed ID: 19791800
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early intraplatelet signaling enhances the release of human platelet PAR-1 and -4 amino-terminal peptides in response to thrombin.
    Ofosu FA, Dewar L, Song Y, Cedrone AC, Hortelano G, Craven SJ.
    Biochemistry; 2009 Feb 24; 48(7):1562-72. PubMed ID: 19182900
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanism of action and clinical development of platelet thrombin receptor antagonists.
    Ueno M, Ferreiro JL, Angiolillo DJ.
    Expert Rev Cardiovasc Ther; 2010 Aug 24; 8(8):1191-200. PubMed ID: 20670195
    [Abstract] [Full Text] [Related]

  • 20. Platelet receptors for adenine nucleotides and thromboxane A2.
    Murugappan S, Shankar H, Kunapuli SP.
    Semin Thromb Hemost; 2004 Aug 24; 30(4):411-8. PubMed ID: 15354262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.